Breathe and Relax: CBD Aerosolizer
Inventors from the Moreau Consultant group envision a new way of consuming cannabinoids – just breathing as usual. U.S. Patent Publication 20220062569 published in early March 2022 describes a device that aerosolizes nano-emulsified cannabinoids and releases them as airborne nano-particles for skin absorption and inhalation into the mucus membranes and lungs.
Variations of the device are depicted in the figures of Pat. Pub. ‘569 and resemble humidifiers and aromatherapy apparatuses. The only cannabinoid claimed for aerosolization is CBD with many others discussed in the specification, so continuation applications are expected for this non-provisional parent application.
A device like this could appeal to many first-time cannabis users who aren’t fully committed to traditional consumption methods such as ingestion or smoking. An aerosolization device as such works similarly to inhalers and provides a healthier consumption route, especially in a passive manner as such. It will be interesting to see if this device reaches market production, and, as we know, patent investment leads market activity and is a sign that a new consumer product could be coming soon.
Learn more about future cannabis products and supporting patents by signing up for the Cannabis Patent Forecast® today!
Related Posts
May 20, 2021
Cannabis Popularity Soars Along With Tests To Detect It
The Duquenois Levine Test is used in the field by law enforcement officers to test for THC presence in a suspected sample. The problem with…
April 15, 2021
Hound Labs, Cannabix and Vox Heat Up the Marijuana Breathalyzer Market
At the start of April 2021, Patent Forecast® released an insight going over some of the big name competitors getting their foot in the door…
April 8, 2021
Driving While High? Cannabis Sobriety Testing Heats Up
What’s the future of cannabis innovation? We see things before they happen using our Patent Forecast®. One of those is the development of…